Results 21 to 30 of about 93,969 (303)

Therapeutic Targets in Allergic Conjunctivitis

open access: yesPharmaceuticals, 2022
Allergic conjunctivitis (AC) is a common condition resulting from exposure to allergens such as pollen, animal dander, or mold. It is typically mediated by allergen-induced crosslinking of immunoglobulin E attached to receptors on primed conjunctival ...
Bisant A Labib, DeGaulle I. Chigbu
semanticscholar   +1 more source

Current Knowledge in Allergic Conjunctivitis

open access: yesTurkish journal of ophthalmology, 2021
Allergic conjunctivitis is a disease of increasing prevalence that affects both children and adults and causes significant deterioration of their quality of life and sometimes irreversible visual damage.
B. Villegas, J. Benítez-Del-Castillo
semanticscholar   +1 more source

Conjunctivitis

open access: yesTNOA Journal of Ophthalmic Science and Research
Josephine S. Christy   +2 more
doaj   +3 more sources

ROLE OF VIRUSES IN THE ETIOLOGY OF FOLLICULAR CONJUNCTIVITIS [PDF]

open access: yesVeterinary Medical Journal - Giza, 1995
Sixty-two cases of clinically diagnosed non-trachomatous conjunctivitis were included in this study. All patients were subjected to through clinical and ophthalmological examination.
OMEIMA MOSTAFA, WAFAA REDA, M BAHGAT
doaj   +1 more source

Expression levels of pro-inflammatory interleukin-8 and certain antimicrobial peptides in concurrent with bacterial conjunctivitis [PDF]

open access: yesInternational Journal of Ophthalmology, 2021
AIM: To detect the quantitative expression levels of the pro-inflammatory interleukin-8 (IL8), antimicrobial peptides human beta defense-2 (HBD2), and human beta defense-3 (HBD3) genes in bacterial conjunctivitis.
Alaa El-Dien Shawky Hosny   +5 more
doaj   +1 more source

Obfuscating Conjunctions [PDF]

open access: yesJournal of Cryptology, 2013
zbMATH Open Web Interface contents unavailable due to conflicting licenses.
Zvika Brakerski, Guy N. Rothblum
openaire   +3 more sources

Conjunctivitis in adult patients with moderate‐to‐severe atopic dermatitis: results from five tralokinumab clinical trials

open access: yesBritish Journal of Dermatology, 2021
Tralokinumab, a fully human IgG4 monoclonal antibody that specifically binds with high affinity to interleukin‐13, effectively reduces moderate‐to‐severe atopic dermatitis (AD) when given every 2 weeks.
A. Wollenberg   +8 more
semanticscholar   +1 more source

Conjunctivitis Patients in the Ophthalmology Outpatient Clinic Dr. Soetomo General Academic Hospital, Surabaya, in 2017

open access: yesJuxta: Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga, 2023
Highlights: 1. Ginger (Zingiber officinale) has antimicrobial activity against UPEC which commonly causes UTI in women. 2. The MIC and MBC of ginger against UPEC in this study was 1000 mg/ml.
Angeline Hartadhi   +2 more
doaj   +1 more source

Conjunctivitis and COVID‐19: A meta‐analysis

open access: yesJournal of Medical Virology, 2020
There are sparse data in literature regarding conjunctivitis incidence in COVID-19 and its relationship with disease severity. The objective of this metanalysis was to assess the association between conjunctivitis and the severity of COVID-19 disease ...
L. Loffredo   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy